X-8170052-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_016378.3(VCX2):āc.400G>Cā(p.Val134Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000036 in 1,195,242 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016378.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VCX2 | NM_016378.3 | c.400G>C | p.Val134Leu | missense_variant | 3/3 | ENST00000317103.5 | NP_057462.2 | |
LOC107985675 | XR_001755783.2 | n.1915-58283C>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VCX2 | ENST00000317103.5 | c.400G>C | p.Val134Leu | missense_variant | 3/3 | 1 | NM_016378.3 | ENSP00000321309 | P1 | |
ENST00000659022.1 | n.972-58283C>G | intron_variant, non_coding_transcript_variant | ||||||||
ENST00000649338.1 | n.263-58283C>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000203 AC: 2AN: 98726Hom.: 0 Cov.: 15 AF XY: 0.00 AC XY: 0AN XY: 22278
GnomAD3 exomes AF: 0.0000110 AC: 2AN: 181740Hom.: 0 AF XY: 0.0000296 AC XY: 2AN XY: 67640
GnomAD4 exome AF: 0.0000374 AC: 41AN: 1096516Hom.: 0 Cov.: 76 AF XY: 0.0000331 AC XY: 12AN XY: 362862
GnomAD4 genome AF: 0.0000203 AC: 2AN: 98726Hom.: 0 Cov.: 15 AF XY: 0.00 AC XY: 0AN XY: 22278
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 21, 2022 | The c.400G>C (p.V134L) alteration is located in exon 3 (coding exon 2) of the VCX2 gene. This alteration results from a G to C substitution at nucleotide position 400, causing the valine (V) at amino acid position 134 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at